C.M. Bidwell & Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-920
| Closed | -$41K | – | 556 |
|
|
2022
Q2 | $41K | Sell |
920
-20
| -2% | -$891 | 0.03% | 291 |
|
|
2022
Q1 | $47K | Hold |
940
| – | – | 0.03% | 288 |
|
|
2021
Q4 | $48K | Buy |
+940
| New | +$48K | 0.03% | 302 |
|
|
2018
Q4 | – | Sell |
-610
| Closed | -$42K | – | 476 |
|
|
2018
Q3 | $42K | Buy |
+610
| New | +$42K | 0.04% | 243 |
|